TY - JOUR
T1 - Hypertensive female Sprague-Dawley rats require an intact nitric oxide synthase system for compensatory increases in renal regulatory T cells
AU - Ramirez, Lindsey A.
AU - Gillis, Ellen E.
AU - Musall, Jacqueline B.
AU - Mohamed, Riyaz
AU - Snyder, Elizabeth
AU - El-Marakby, Ahmed
AU - Sullivan, Jennifer C.
N1 - Funding Information:
This work was funded by National Institutes of Health Grants R01HL127091 and P01HL134604 (to J. C. Sullivan) and by American Heart Association Grant 17EIA33410565 (to J. C. Sullivan).
Publisher Copyright:
Copyright © 2020 the American Physiological Society
PY - 2020/8
Y1 - 2020/8
N2 - We have previously shown that hypertensive female rats have more regulatory T cells (Tregs), which contribute more to blood pressure (BP) control in female versus male rats. Based on known protective properties of Tregs, the goal of the present study was to investigate the mechanisms by which female rats maintain Tregs. The present study was designed to 1) compare the impact of three hypertension models on the percentage of renal Tregs and 2) test the hypothesis that nitric oxide synthase (NOS) inhibition prevents increases in renal Tregs and exacerbates renal damage in female Sprague-Dawley rats. Rats (11–14 wk old) were randomized to one of the following four groups: control, norepinephrine (NE) infusion, angiotensin II infusion, or the NOS inhibitor Nώ-nitro-L-arginine methyl ester (L-NAME) in drinking water. BP was measured via tail cuff. After 2 wk of treatment, kidneys were isolated and processed to measure Tregs via flow cytometric analysis and renal injury via urinary albumin excretion, plasma creatinine, and histological analyses. Hypertensive treatments increased BP in all experimental animals. Increases in BP in norepinephrine-and angiotensin II-treated rats were associated with increases in renal Tregs versus control. In contrast, L-NAME treatment decreased Tregs compared with all groups. L-NAME treatment modestly increased albumin excretion. However, plasma creatinine was comparable among the groups, and there was no histological evidence of glomerular or tubular injury. This study provides insights into the mechanisms regulating renal Tregs and supports that an intact NOS system is crucial for female rats to have BP-related increases in renal Tregs.
AB - We have previously shown that hypertensive female rats have more regulatory T cells (Tregs), which contribute more to blood pressure (BP) control in female versus male rats. Based on known protective properties of Tregs, the goal of the present study was to investigate the mechanisms by which female rats maintain Tregs. The present study was designed to 1) compare the impact of three hypertension models on the percentage of renal Tregs and 2) test the hypothesis that nitric oxide synthase (NOS) inhibition prevents increases in renal Tregs and exacerbates renal damage in female Sprague-Dawley rats. Rats (11–14 wk old) were randomized to one of the following four groups: control, norepinephrine (NE) infusion, angiotensin II infusion, or the NOS inhibitor Nώ-nitro-L-arginine methyl ester (L-NAME) in drinking water. BP was measured via tail cuff. After 2 wk of treatment, kidneys were isolated and processed to measure Tregs via flow cytometric analysis and renal injury via urinary albumin excretion, plasma creatinine, and histological analyses. Hypertensive treatments increased BP in all experimental animals. Increases in BP in norepinephrine-and angiotensin II-treated rats were associated with increases in renal Tregs versus control. In contrast, L-NAME treatment decreased Tregs compared with all groups. L-NAME treatment modestly increased albumin excretion. However, plasma creatinine was comparable among the groups, and there was no histological evidence of glomerular or tubular injury. This study provides insights into the mechanisms regulating renal Tregs and supports that an intact NOS system is crucial for female rats to have BP-related increases in renal Tregs.
KW - Angiotensin II
KW - Blood pressure
KW - N -nitro-L-arginine methyl ester
KW - Norepinephrine
UR - http://www.scopus.com/inward/record.url?scp=85088495316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088495316&partnerID=8YFLogxK
U2 - 10.1152/ajprenal.00228.2020
DO - 10.1152/ajprenal.00228.2020
M3 - Article
C2 - 32597687
AN - SCOPUS:85088495316
SN - 0363-6135
VL - 319
SP - F192-F201
JO - American Journal of Physiology - Heart and Circulatory Physiology
JF - American Journal of Physiology - Heart and Circulatory Physiology
IS - 2
ER -